 | ||||||
| "anti diabetes" | ||||||
| NEWS | ||||||
| Lilly and Boehringer closing in on diabetes market lead with Jardiance approval “The companies will soon market drugs from every anti-diabetes class, which will strengthen their relationship with buyers,” the analyst concludes.
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.